New topics |
| Good Results with Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Perfusion for Recurrent Ovarian Cancer: Presented at ICACT |
| By Jill Stein
PARIS, FRANCE -- February 1, 2006 -- Cytoreductive surgery with intraperitoneal hyperthermic perfusion seems to be an effective and well tolerated treatment for women with recurrent peritoneal ovarian cancer, ac... read more |
| Heated chemotherapy prolongs survival in abdominal cancerl |
| Last Updated: 2005-03-07
NEW YORK (Reuters Health) - Intraperitoneal injection of hyperthermic chemotherapy (IPHC) following cytoreductive surgery lengthens overall survival in patients with peritoneal dissemination of GI neo... read more |
| Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion Beneficial in Recurrent Ovarian Carcinoma |
| ICACT: Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion Beneficial in Recurrent Ovarian Carcinoma
By Chris Berrie PARIS, FRANCE -- February 2, 2005 -- Cytoreductive surgery plus hypertherma... read more |
| Leading Sydney surgeon quits hospital in protest at deadly delays |
| Wed Feb 23,12:09 PM ET
SYDNEY (AFP) - A leading Australian surgeon has resigned from a Sydney hospital in protest at lengthy surgery waiting lists that he said had resulted in patient deaths. David Morr... read more |
| Patient age tied to management of terminal cancer |
| January 12, 2005
NEW YORK (Reuters Health) - The concerns of older patients with advanced cancer appear to be given more weight in treatment decisions than are those of their middle-age counterparts, according to a study of m... read more |
| Genentech colon cancer drug effective in combination regimen |
| NEW YORK (Reuters) - Cancer patients treated with Genentech Inc.'s colon cancer drug bevacizumab (Avastin) along with the chemotherapy regimen FOLFOX4 lived longer than patients treated with the chemotherapy alone in a late-stage clinical t... read more |
 |